CANF | tickerfilter.com

Fundamental analysis

26%

Profitability 25%

Dept financing 12%

Liquidity 46%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-6.33%

1 Month

-32.73%

3 Months

-5.93%

6 Months

6.73%

1 Year

-22.11%

2 Year

-76.06%

Key data

Stock price

$2.21

P/E Ratio

0.00

DAY RANGE

$2.10 - $2.36

EPS

$0.00

52 WEEK RANGE

$1.81 - $4.69

52 WEEK CHANGE

-$0.23

MARKET CAP

3.422 M

YIELD

N/A

SHARES OUTSTANDING

1.541 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.89

PUBLIC FLOAT

AVERAGE 10 VOLUME

$58,230

AVERAGE 30 VOLUME

$74,383

Company detail

CEO: Pnina Fishman
Region: US
Website: http://www.canfite.com/
Employees: 5
IPO year: -

Issue type: American Depository Receipt (ADR’s)
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

can fite biopharma (canfy) is a biotechnology company based out of 10 bareket street, פ"ת, israel.

CANF - Can-Fite Biopharma Ltd - ADR